These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12146812)

  • 21. Development and validation of culture-specific Variable Response Inconsistency and True Response Inconsistency scales for use with the Korean MMPI-2.
    Ketterer HL; Han K; Hur J; Moon K
    Psychol Assess; 2010 Sep; 22(3):504-19. PubMed ID: 20822263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examination of the MMPI-2 restructured form (MMPI-2-RF) validity scales in civil forensic settings: findings from simulation and known group samples.
    Wygant DB; Ben-Porath YS; Arbisi PA; Berry DT; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2009 Nov; 24(7):671-80. PubMed ID: 19797242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Internal structure of the MMPI-2 Addiction Potential Scale in alcoholic and psychiatric inpatients.
    Sawrie SM; Kabat MH; Dietz CB; Greene RL; Arredondo R; Mann AW
    J Pers Assess; 1996 Feb; 66(1):177-93. PubMed ID: 8576831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of the NEO-PI-R validity scales to detect response distortion: a comparison with the MMPI-2.
    Morasco BJ; Gfeller JD; Elder KA
    J Pers Assess; 2007 Jun; 88(3):276-83. PubMed ID: 17518549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting malingered and defensive responding on the MMPI-2 in a forensic inpatient sample.
    Bagby RM; Rogers R; Buis T
    J Pers Assess; 1994 Apr; 62(2):191-203. PubMed ID: 8189330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Readministration of the MMPI-2 following defensive invalidation in a military job applicant sample.
    Cigrang JA; Staal MA
    J Pers Assess; 2001 Jun; 76(3):472-81. PubMed ID: 11499459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faking bad and faking good by college students on the Korean MMPI-2.
    Hahn J
    J Pers Assess; 2005 Aug; 85(1):65-73. PubMed ID: 16083385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting symptom exaggeration in combat veterans using the MMPI-2 symptom validity scales: a mixed group validation.
    Tolin DF; Steenkamp MM; Marx BP; Litz BT
    Psychol Assess; 2010 Dec; 22(4):729-36. PubMed ID: 21038968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiating psychotic patients from nonpsychotic patients with the MMPI-2 and Rorschach.
    Dao TK; Prevatt F; Horne HL
    J Pers Assess; 2008 Jan; 90(1):93-101. PubMed ID: 18444100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MMPI-2 profiles of women with eating disorders in a Dutch day treatment sample.
    Exterkate CC; Bakker-Brehm DT; de Jong CA
    J Pers Assess; 2007 Apr; 88(2):178-86. PubMed ID: 17437383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updating the Jesness Inventory randomness validity scales for the Jesness Inventory-Revised.
    Pinsoneault TB
    J Pers Assess; 2006 Apr; 86(2):190-5. PubMed ID: 16599793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the MMPI-2's VRIN scale with severely disturbed populations: consistent responding may be more problematic than inconsistent responding.
    Stukenberg K; Brady C; Klinetob N
    Psychol Rep; 2000 Feb; 86(1):3-14. PubMed ID: 10778242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The predictive capacity of the MMPI-2 and PAI validity scales and indexes to detect coached and uncoached feigning.
    Bagby RM; Nicholson RA; Bacchiochi JR; Ryder AG; Bury AS
    J Pers Assess; 2002 Feb; 78(1):69-86. PubMed ID: 11936213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An investigation of the psychometric properties of the MMPI-2 Restructured Clinical (RC) scales with mental health inpatients.
    Handel RW; Archer RP
    J Pers Assess; 2008 May; 90(3):239-49. PubMed ID: 18444120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the MCMI-III personality disorder and modifier indices with the MMPI-2 clinical and validity scales.
    Schoenberg MR; Dorr D; Morgan CD; Burke M
    J Pers Assess; 2004 Jun; 82(3):273-80. PubMed ID: 15151803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of the items-easy (Ie) and items-difficult (Id) subscales for the MMPI-A.
    Krakauer SY; Archer RP; Gordon RA
    J Pers Assess; 1993 Jun; 60(3):561-71. PubMed ID: 16370813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMPI-2: Confidence intervals for random responding to the F, F Back, and VRIN scales.
    Charter RA; Lopez MN
    J Clin Psychol; 2003 Sep; 59(9):985-90. PubMed ID: 12945063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing depression with the MMPI and MMPI-2.
    Gross K; Keyes MD; Greene RL
    J Pers Assess; 2000 Dec; 75(3):464-77. PubMed ID: 11117157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A perspective on the Restructured Clinical (RC) Scale Project.
    Archer RP
    J Pers Assess; 2006 Oct; 87(2):179-85. PubMed ID: 16972821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syndromal complexity, paradigm shifts, and the future of validation research: comments on Nichols and Rogers, Sewell, Harrison, and Jordan.
    Weed NC
    J Pers Assess; 2006 Oct; 87(2):217-22. PubMed ID: 16972826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.